Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/76421COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.author | Mallol, Josefa | - |
| dc.contributor.author | Albericio, Fernando | - |
| dc.contributor.author | Royo, Miriam | - |
| dc.contributor.author | Casadó, Vicent | - |
| dc.date.accessioned | 2013-05-21T11:01:44Z | - |
| dc.date.available | 2013-05-21T11:01:44Z | - |
| dc.date.issued | 2010 | - |
| dc.identifier | doi: 10.1124/jpet.109.158824 | - |
| dc.identifier | issn: 0022-3565 | - |
| dc.identifier | e-issn: 1521-0103 | - |
| dc.identifier.citation | Journal of Pharmacology and Experimental Therapeutics 332(3): 876-885 (2010) | - |
| dc.identifier.uri | http://hdl.handle.net/10261/76421 | - |
| dc.description | et al. | - |
| dc.description.abstract | The indoloquinolizidine-peptide 28 [(3S,12bR)-N-((S)-1-((S)-1-((S)-2- carbamoylpyrrolidin-1-yl)-3-(4-fluorophenyl)-1-oxopropan-2-ylamino) -4-cyclohexyl-1-oxobutan-2-yl)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a] quinolizine-3-carboxamide], a transindoloquinolizidine-peptide hybrid obtained by a combinatorial approach, behaved as an orthosteric ligand of all dopamine D2-like receptors (D2, D3, and D4) and dopamine D5 receptors, but as a negative allosteric modulator of agonist and antagonist binding to striatal dopamine D1 receptors. Indoloquinolizidine-peptide 28 induced a concentration-dependent hyperbolic increase in the antagonist apparent equilibrium dissociation constant values and altered the dissociation kinetics of dopamine D1 receptor antagonists. The negative allosteric modulation was also found when agonist binding to D1 receptors was assayed. Indoloquinolizidine-peptide 28 was a weak ago-allosteric modulator but markedly led to a decreased potency without decreasing the maximum partial/full agonist-mediated effect on cAMP levels. Compounds able to decrease the potency while preserving the efficacy of D1 receptor agonists are promising for exploration in psychotic pathologies. Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics. | - |
| dc.description.sponsorship | This work was supported by the Spanish Ministerio de Ciencia y Tecnología [Grants SAF2008-00146, SAF2009-07276] (to E.I.C. and R.F., respectively); and Fundació La Marató de TV3 [Grant 060110 ] (to E.I.C.). | - |
| dc.language.iso | eng | - |
| dc.publisher | American Society for Pharmacology and Experimental Therapeutics | - |
| dc.rights | closedAccess | - |
| dc.title | A hybrid indoloquinolizidine peptide as allosteric modulator of dopamine D1 receptors | - |
| dc.type | artículo | - |
| dc.identifier.doi | 10.1124/jpet.109.158824 | - |
| dc.date.updated | 2013-05-21T11:01:44Z | - |
| dc.description.version | Peer Reviewed | - |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
| item.openairetype | artículo | - |
| item.grantfulltext | none | - |
| item.cerifentitytype | Publications | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | No Fulltext | - |
| item.languageiso639-1 | en | - |
| Aparece en las colecciones: | (IIBB) Artículos | |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| accesoRestringido.pdf | 15,38 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
14
checked on 02-abr-2024
WEB OF SCIENCETM
Citations
13
checked on 27-feb-2024
Page view(s)
319
checked on 19-abr-2024
Download(s)
107
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.